HomeCompareABTZY vs MRK

ABTZY vs MRK: Dividend Comparison 2026

ABTZY yields 3.75% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $28.4K in total portfolio value
10 years
ABTZY
ABTZY
● Live price
3.75%
Share price
$5.07
Annual div
$0.19
5Y div CAGR
7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.4K
Annual income
$1,026.56
Full ABTZY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ABTZY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABTZYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABTZY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABTZY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABTZY
Annual income on $10K today (after 15% tax)
$318.54/yr
After 10yr DRIP, annual income (after tax)
$872.58/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,455.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABTZY + MRK for your $10,000?

ABTZY: 50%MRK: 50%
100% MRK50/50100% ABTZY
Portfolio after 10yr
$42.6K
Annual income
$5,412.35/yr
Blended yield
12.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ABTZY
No analyst data
Altman Z
0.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABTZY buys
0
MRK buys
0
No recent congressional trades found for ABTZY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABTZYMRK
Forward yield3.75%2.76%
Annual dividend / share$0.19$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR7%32.7%
Portfolio after 10y$28.4K$56.8K
Annual income after 10y$1,026.56$9,798.13
Total dividends collected$6.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ABTZY vs MRK ($10,000, DRIP)

YearABTZY PortfolioABTZY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,101$400.99$11,206$366.19$105.00MRK
2$12,323$445.13$12,650$502.35$327.00MRK
3$13,680$494.14$14,407$694.19$727.00MRK
4$15,186$548.55$16,585$967.82$1.4KMRK
5$16,858$608.94$19,342$1,363.89$2.5KMRK
6$18,714$675.99$22,913$1,947.19$4.2KMRK
7$20,775$750.41$27,662$2,823.89$6.9KMRK
8$23,062$833.03$34,159$4,173.35$11.1KMRK
9$25,601$924.74$43,337$6,308.80$17.7KMRK
10$28,419$1,026.56$56,776$9,798.13$28.4KMRK

ABTZY vs MRK: Complete Analysis 2026

ABTZYStock

Aboitiz Equity Ventures, Inc., a conglomerate, engages in the power, financial services, food manufacturing, real estate, and infrastructure businesses in the Philippines and internationally. It is involved in the power generation, distribution, and retail of electricity supply; provision of banking and financial services; production of feeds and flour, hog and layer farm, and animal nutrition products; and development of residential communities. The company also offers water and wastewater-related services to residential, commercial, and industrial customers; digital infrastructure services; operates regional airports; operates integrated economic estates projects; and manufactures and distributes cement. In addition, it provides aviation services; insurance products; and portfolio investment services. The company was formerly known as Cebu Pan Asian Holdings, Inc. and changed its name to Aboitiz Equity Ventures, Inc. in December 1993. Aboitiz Equity Ventures, Inc. was incorporated in 1989 and is headquartered in Taguig City, the Philippines.

Full ABTZY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ABTZY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABTZY vs SCHDABTZY vs JEPIABTZY vs OABTZY vs KOABTZY vs MAINABTZY vs JNJABTZY vs ABBVABTZY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.